2025 Annual Meeting | C44 - Update in Movement Disorders

Date Sunday 04/06/25

Time 07:00 AM - 09:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Andres F. Deik Acosta Madiedo, MD, FAAN

Topic(s) Movement Disorders

Learning Objectives Participants should become familiar with recent advances in the field of movement disorders, particularly pertaining to the application of artificial intelligence, newly established diagnostics and pharmacologic therapies, and deep brain stimulation and focused ultrasound for different indications.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider, Medical Student

Teaching Styles Didactic, Audience Participation

Event Timeline
07:00 AM - 07:05 AM PDT	Introduction	Audience welcome Andres F. Deik Acosta Madiedo, MD, FAAN
07:05 AM - 07:40 AM PDT	Speaker	Advances in diagnostics and pharmacologic therapeutics of Movement Disorders Mayela D. Rodriguez Violante, MD
07:40 AM - 08:15 AM PDT	Speaker	New developments in Deep Brain Stimulation and Focused Ultrasound for Movement Disorders Maria Fiorella Contarino
08:15 AM - 08:45 AM PDT	Speaker	The rapidly evolving role of AI in the management of Movement Disorders Andres F. Deik Acosta Madiedo, MD, FAAN
08:45 AM - 09:00 AM PDT	Q&A	Questions, answers and closing remarks Andres F. Deik Acosta Madiedo, MD, FAAN, Maria Fiorella Contarino, Mayela D. Rodriguez Violante, MD

Faculty Disclosures
Andres F. Deik Acosta Madiedo, MD, FAAN	Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus Therapeutics. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie. Dr. Deik Acosta Madiedo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Deik Acosta Madiedo has received research support from Teva Pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Cerevel Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Prevail Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from Lundbeck Therapeutics. The institution of Dr. Deik Acosta Madiedo has received research support from AskBio. The institution of Dr. Deik Acosta Madiedo has received research support from Annovis Bio. The institution of Dr. Deik Acosta Madiedo has received research support from Ono pharmaceuticals. The institution of Dr. Deik Acosta Madiedo has received research support from Amylyx therapeutics. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care. Dr. Deik Acosta Madiedo has received publishing royalties from a publication relating to health care.
Maria Fiorella Contarino	No disclosure on file
Mayela D. Rodriguez Violante, MD	No disclosure on file